Strongyloidiasis treatments, including pharmacological therapies such as ivermectin, albendazole, and mebendazole, are increasingly vital components of parasitic infection management in both endemic and non-endemic regions due to their proven efficacy, safety profile, and widespread adoption in healthcare systems https://www.databridgemarketresearch.com/reports/global-strongyloidiasis-treatment-market